By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics today reported a slight rise in its first-quarter revenues and a 6 percent increase in its net loss year over year.

The microRNA-based diagnostics firm reported total revenues of $27,000 for the three-month period ended March 31, compared to $17,000 for the first quarter of 2009.

Rosetta's net loss for the quarter was $3.6 million, or $.22 per share, compared to $3.4 million, or $.30 per share, for Q1 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.